Zura Total Current Liabilities from 2010 to 2024
| ZURA Stock | 2.93 0.03 1.03% |
Total Current Liabilities | First Reported 2010-12-31 | Previous Quarter 20.3 M | Current Value 12.9 M | Quarterly Volatility 6.8 M |
Check Zura Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zura Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 168.8 K, Other Operating Expenses of 65.8 M or Total Operating Expenses of 65.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.3. Zura financial statements analysis is a perfect complement when working with Zura Bio Valuation or Volatility modules.
Zura |
Latest Zura Bio's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Zura Bio Limited over the last few years. Total Current Liabilities is an item on Zura Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Zura Bio Limited are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Zura Bio's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zura Bio's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Zura Total Current Liabilities Regression Statistics
| Arithmetic Mean | 3,231,976 | |
| Geometric Mean | 129,448 | |
| Coefficient Of Variation | 209.41 | |
| Mean Deviation | 5,108,761 | |
| Median | 39,000 | |
| Standard Deviation | 6,767,949 | |
| Sample Variance | 45.8T | |
| Range | 20.3M | |
| R-Value | 0.67 | |
| Mean Square Error | 26.9T | |
| R-Squared | 0.45 | |
| Significance | 0.01 | |
| Slope | 1,019,434 | |
| Total Sum of Squares | 641.3T |
Zura Total Current Liabilities History
About Zura Bio Financial Statements
Zura Bio stakeholders use historical fundamental indicators, such as Zura Bio's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Zura Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Zura Bio's assets and liabilities are reflected in the revenues and expenses on Zura Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Zura Bio Limited. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 20.3 M | 12.9 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock:Check out the analysis of Zura Bio Correlation against competitors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. If investors know Zura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zura Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.57 | Return On Assets (0.21) | Return On Equity (0.37) |
The market value of Zura Bio Limited is measured differently than its book value, which is the value of Zura that is recorded on the company's balance sheet. Investors also form their own opinion of Zura Bio's value that differs from its market value or its book value, called intrinsic value, which is Zura Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zura Bio's market value can be influenced by many factors that don't directly affect Zura Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zura Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.